N. lactamica

BIOLOGICAL2 trials

Sponsors

University of Southampton

Conditions

Meningitis, BacterialNeisseria Infection

Early Phase 1

Challenge of the Nasopharynx With Neisseria Lactamica Expressing the Meningococcal Protein Neisseria Adhesin A (NadA)

CompletedNCT03630250

University of SouthamptonMeningitis, Bacterial, Neisseria Infection

Start: 2018-10-18End: 2019-09-01Updated: 2020-02-27

Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica

CompletedNCT03633474

University of SouthamptonMeningitis, Bacterial

Start: 2018-09-01End: 2019-09-01Updated: 2019-10-22

Related Papers

Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.

2022-12-0111 citations

Protocol for a controlled human infection with genetically modified<i>Neisseria lactamica</i>expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine

BMJ Open2019-04-019 citations